Boston Scientific sales down $822M in 2020
Photo | Grant Welker
Boston Scientific headquarters in Marlborough
Marlborough medical device company Boston Scientific reported a net sales decline of $822 million in 2020, with losses across the board accounting for a 7.7% drop from 2019’s sales. However, the company’s stock price actually increased based on the potential from upcoming acquisitions.
In addition to the sales decline, the company reported on Wednesday a net loss of $173 million, or $0.12 per share, compared to a profit of $4.7 billion in 2019.
The company also reported a fourth quarter decline of 6.8% in sales, down to $2.7 billion from sales in the fourth quarter of 2019 of $2.9 billion.
Despite the declines, the company’s stock is up more than 3.5% since the announcement to $38.74 a share. This growth has been attributed to the potential its acquisition of Preventice Solutions, which is expected to close in the middle of next year, could have on its earning potential.
WBJ Web Partners
Most Recent
Most Recent
0 Comments